It is common for girls with CPP to be overweight or obese at the time of diagnosis, but there are conflicting results as to whether weight is increased during or after receiving treatment with GnRH analogs (GnRHa), because there are studies indicating that the BMI increases and in others that it decreases (8–13). The gene discussed is GNRH1; the disease is central precocious puberty.